WeightWatchers going into prescription weight loss business with telehealth provider acquisition
CBC
WeightWatchers' stock soared on Tuesday after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence.
Sequence is a telehealth provider that offers users access to drugs used to treat diabetes and obesity under such brand names as Ozempic, Wegovy and Trulicity.
The drugs all work by the same mechanism: They trigger the release of insulin, block sugar production in the liver and suppress appetite.
WeightWatchers offers subscribers meal plans with the goal of losing excess weight. With the acquisition of Sequence, it is tapping into a red-hot market for prescription drugs that address obesity and broadening what it offers to customers.
"It is our responsibility, as the trusted leader in weight management, to support those interested in exploring if medications are right for them," CEO Sima Sistani said in a prepared statement late Monday.
Ozempic and Wegovy are different versions of the same drug, known as semaglutide.
They're both given as once-weekly injections. Ozempic is approved only to treat diabetes, although it has been increasingly prescribed for off-label use.
Wegovy was approved in 2021 to treat obesity in adults, and late last year to treat the condition in adolescents 12 and older. In a clinical trial, adults who used Wegovy lost about 15 per cent of their initial body weight, while teens lost slightly more.
For best results, the drugs should be combined with diet and exercise, experts say. Trulicity is a different drug, dulaglutide, used to treat diabetes in adults and children ages 10 and older. It's not approved to treat obesity.
The off-label use of semaglutide, spurred by social media posts, led to a shortage of the drug for most of last year. Novo Nordisk said supplies are being replenished, but many diabetes patients still report trouble accessing the drugs they need.
Both Ozempic and Wegovy can cause possible side-effects, the company reports. They include possible thyroid cancer, pancreatitis, and kidney and gallbladder problems.
The most common side-effects are nausea, vomiting, diarrhea, stomach pain and constipation. Obesity prevalence rose from 30.5 per cent from the 1999-2000 period to 41.9 per cent for 2017 through March 2020, according to the U.S. Centers for Disease Control and Prevention (CDC). The prevalence of severe obesity surged from 4.7 per cent to 9.2 per cent for the same periods.
Currently, Wegovy and Saxenda are approved drugs for obesity in the United States, with tirzepatide also widely expected to be approved for it later this year.
In December, Eli Lilly CEO David Ricks called the drug one of its "generational opportunities." The drug was last year approved for diabetes, for which it is sold under the brand Mounjaro.
The Canadian government has lost in court — again — to a First Nations grandmother fighting to fix extensive mould at her home on Oneida Nation of the Thames, near London, Ont.
Indigenous community members in British Columbia say they are celebrating after OneBC said it had removed MLA Dallas Brodie as its party leader.
Before NASA astronaut Sally Ride’s historic launch aboard the space shuttle in 1983 as the first American woman in space, she was asked a question: Would 100 tampons be the right number for her week-long mission?
Ashley Stevens has scars inside and out from her time in an Ontario jail.
Winnipeg resident John Ruhland first began taking medication for his depression in 2000 when a period of enormous stress — both at work and in his personal life — landed him in the hospital.
A group of young adults from Cumberland House Cree Nation travelled to British Columbia in November to take part in a program designed help them develop the skills needed to succeed should they decide to move away from their home northeast of Saskatoon.
In just a few short months, Canadian astronaut Jeremy Hansen will make history.
Chiefs from Treaty 8 First Nations of Alberta are calling for a pause on the pipeline memorandum of understanding until they are consulted and sign off on the potential project. And they're threatening legal action if that doesn't happen.
When dolphins swam onto the scene during a study on northern resident orcas off the coast of B.C., at least one researcher admitted to being a little annoyed.
Researchers say there's been a dramatic rise in the number of people going on medications to treat attention deficit/hyperactivity disorder in Ontario, suggesting factors such as more time spent online and the rise of private assessments for the mental condition could be behind the increase.
Baby, it’s cold outside — but it’s worth putting on that heavy winter coat, scarf and boots and heading out for one of the best meteor showers of the year: the Geminids.
Health officials are reminding Canadians to maintain healthy habits during the holiday season, as influenza leads to more school absences and hospitalizations.
For 40 years, staff at Nova Scotia's Annapolis Royal Historic Gardens thought their ginkgo tree was male.